Loading...
Association of survival benefit with docetaxel in prostate cancer and total number of cycles administered: a post hoc analysis of the Mainsail Study.
de Morrée, E Vogelzang, N Petrylak, D Budnik, N Wiechno, P Sternberg, C Doner, K Bellmunt, J Burke, J Ochoa de Olza, M
de Morrée, E
Vogelzang, N
Petrylak, D
Budnik, N
Wiechno, P
Sternberg, C
Doner, K
Bellmunt, J
Burke, J
Ochoa de Olza, M
Citations
Altmetric:
Abstract
The optimal total number of docetaxel cycles in patients with metastatic castration resistant prostate cancer (mCPRC) has not been investigated yet. It is unknown whether it is beneficial for patients to continue treatment upon 6 cycles.
Description
Date
2016-08-25
Publisher
Collections
Files
Loading...
From UNPAYWALL
Adobe PDF, 326.86 KB
Keywords
Type
Article
Citation
Association of survival benefit with docetaxel in prostate cancer and total number of cycles administered: a post hoc analysis of the Mainsail Study. 2016, JAMA Oncol